These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11467351

  • 1. Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.
    Blonde L, Sandberg MI.
    Diabetes Technol Ther; 2000; 2(3):479-80. PubMed ID: 11467351
    [No Abstract] [Full Text] [Related]

  • 2. Glyburide/metformin (Glucovance) for type 2 diabetes.
    Med Lett Drugs Ther; 2000 Nov 13; 42(1092):105-6. PubMed ID: 11077467
    [No Abstract] [Full Text] [Related]

  • 3. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.
    Dailey GE.
    Expert Opin Pharmacother; 2003 Aug 13; 4(8):1417-30. PubMed ID: 12877648
    [Abstract] [Full Text] [Related]

  • 4. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R, Reyes-García G, Mateos-García E.
    Proc West Pharmacol Soc; 2002 Aug 13; 45():137-8. PubMed ID: 12434558
    [No Abstract] [Full Text] [Related]

  • 5. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R, Reyes-García G, Mateos-García E.
    Proc West Pharmacol Soc; 2002 Aug 13; 45():139-40. PubMed ID: 12434559
    [No Abstract] [Full Text] [Related]

  • 6. Glyburide/metformin HCl clinical overview.
    Seymour A.
    Manag Care; 2001 Feb 13; 10(2 Suppl):11-6. PubMed ID: 11729403
    [No Abstract] [Full Text] [Related]

  • 7. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
    Duckworth W, Marcelli M, Padden M, Kellick K, Duhancik T, Wilhardt M, Colgan K, Romie A.
    J Manag Care Pharm; 2003 Feb 13; 9(3):256-62. PubMed ID: 14613469
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.
    Donahue SR, Turner KC, Patel S.
    Clin Pharmacokinet; 2002 Feb 13; 41(15):1301-9. PubMed ID: 12452739
    [Abstract] [Full Text] [Related]

  • 9. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
    Potur RG, Gafiţanu E.
    Rev Med Chir Soc Med Nat Iasi; 2010 Feb 13; 114(4):1219-26. PubMed ID: 21500483
    [Abstract] [Full Text] [Related]

  • 10. Unsurpassed glycaemic control made simple.
    Cardiovasc J S Afr; 2003 Feb 13; 14(5):288. PubMed ID: 14664235
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.
    Bokhari SU, Gopal UM, Duckworth WC.
    Am J Med Sci; 2003 Feb 13; 325(2):66-9. PubMed ID: 12589230
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
    Garber AJ, Donovan DS, Dandona P, Bruce S, Park JS.
    J Clin Endocrinol Metab; 2003 Aug 13; 88(8):3598-604. PubMed ID: 12915642
    [Abstract] [Full Text] [Related]

  • 13. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S, COM06 Study Investigators.
    Nutr Metab Cardiovasc Dis; 2008 Jun 13; 18(5):373-9. PubMed ID: 17919894
    [Abstract] [Full Text] [Related]

  • 14. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
    Howlett H, Porte F, Allavoine T, Kuhn T, Nicholson G.
    Curr Med Res Opin; 2003 Jun 13; 19(3):218-25. PubMed ID: 12803736
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E, Nigi L, Patti A, Fondelli C, Dotta F.
    Expert Opin Pharmacother; 2012 Jun 13; 13(9):1377-84. PubMed ID: 22397507
    [Abstract] [Full Text] [Related]

  • 16. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
    Blonde L, Wogen J, Kreilick C, Seymour AA.
    Diabetes Obes Metab; 2003 Nov 13; 5(6):424-31. PubMed ID: 14617228
    [Abstract] [Full Text] [Related]

  • 17. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.
    Chien HH, Chang CT, Chu NF, Hsieh SH, Huang YY, Lee IT, Lee WJ, Tang YJ, Sheu WH.
    J Chin Med Assoc; 2007 Nov 13; 70(11):473-80. PubMed ID: 18063500
    [Abstract] [Full Text] [Related]

  • 18. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P.
    Rev Epidemiol Sante Publique; 1999 Mar 13; 47(1):93-5. PubMed ID: 10214683
    [No Abstract] [Full Text] [Related]

  • 19. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A, Hayes JD, Seidner R, Marchione V, Snyder CM, Mayes K, Stiernberg CM, Milgram L.
    Manag Care; 2001 Feb 13; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract] [Full Text] [Related]

  • 20. Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.
    Davidson JA, Scheen AJ, Howlett HC.
    Drug Saf; 2004 Feb 13; 27(15):1205-16. PubMed ID: 15588116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.